Source: EIN Presswire

Press Release: CMTA : CMTA Invests $423K in Transformative Genomic Research to Advance CMT Diagnostics

CMTA invests $423K in genomic research to close CMT diagnostic gaps, advance gene discovery, and expand the GENESIS platform, driving progress toward a cure.GLENOLDEN, PA, UNITED STATES, February 4, 2025 /⁨EINPresswire.com⁩/ -- The Charcot-Marie-Tooth ...

Read full article »
Est. Annual Revenue
$100-500M
Est. Employees
1.0-5.0K
James Benson's photo - President of CMTA

President

James Benson

CEO Approval Rating

90/100

Read more